Join us on November 12th for our U.S. & Gulf Coast Region Industrial Market Outlook! RSVP Today!
Sales & Support: +1 800 762 3361
Member Resources

Pharmaceuticals company Boehringer Ingelheim expects to invest more than $50 million in its Xochimilco plant in Mexico, with the aim of increasing and improving production by its diabetes segment in the next three years. The company also plans to invest $25 million in its veterinary products plant in Guadalajara, with an expansion to be completed in 2021.

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×

Contact Us

For More Info!